Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

iovera

Explore full profile

MyoScience develops and commercializes technology-driven dermatological products

Fremont, United StatesFounded 2005Biotech & Life Sciences
Valuation $100–250M Last recorded · 2026
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for iovera and the history behind them.

About iovera

Myoscience operates in the medical technology sector, specializing in cryoanalgesia solutions designed to provide immediate and long-lasting non-opioid pain relief. The company's core product is a handheld device that targets both superficial and deep nerves, making it suitable for various clinical settings. Myoscience primarily serves healthcare providers, including doctors and clinics, who incorporate their technology into pain management practices. The business model revolves around selling these advanced medical devices and offering comprehensive support and resources to healthcare professionals for effective implementation. Revenue is generated through direct sales of the devices and potentially through service agreements for ongoing support and training.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2005
Headquarters
Fremont, United States
Employees
23
Open positions
None listed
Dealroom signal
37.6/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Charity, Accounting, Intellectual Property, Testing, Verification, Risk Management, Biotechnology, Neurology, Dermatology
Business model
Manufacturing
Client focus
b2c

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
FundingOther financing Jun 2026 $70M — Zimmer Biomet ↗
ACQUISITIONOther financing Mar 2019 $220M $220M Pacira Biosciences —
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Growth signals

iovera website traffic

Latest recorded traffic for iovera is 5.3K monthly website visits. iovera's team declined 14.8% over the past year.

Latest monthly visits5.3K 1-year team growth-14.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Nexus Medical Partners
  • Saratoga Ventures
  • DeNovo Ventures
  • Accuitive Medical Ventures
  • Valiance Asset Management

Series B and later1 investor entered at this stage

  • Medicis Capital

Other known investors2 additional known investors

  • Pacira Biosciences
  • Zimmer Biomet
Team profiled 16 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Fremont HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about iovera on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See iovera’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.